Emerging strategies to overcome ovarian cancer: advances in immunotherapy
Ovarian cancer is the second most common malignant neoplasm of gynecological origin and the leading cause of death from cancer in the female reproductive system worldwide. This scenario is largely due to late diagnoses, often in advanced stages, and the development of chemoresistance by cancer cells...
Saved in:
| Main Authors: | Tatiana Massariol Pimenta, Josiany Carlos de Souza, Bárbara da Silva Martins, Solenny Maria Silva Butzene, José Matheus Simões Padilha, Milleny Ganho Marçal, Guilherme dos Santos Elias, Leticia Batista Azevedo Rangel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1490896/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer
by: Nayara Gusmão Tessarollo, et al.
Published: (2025-06-01) -
Overcoming immunotherapy resistance in glioblastoma: challenges and emerging strategies
by: Maowu Fu, et al.
Published: (2025-03-01) -
Editorial: Current trends in immunotherapy: from monoclonal antibodies to CAR-T cells
by: Kishor Pant, et al.
Published: (2025-06-01) -
11th Immunotherapy of Cancer conference (ITOC): A meeting report
by: Stefanos Michaelides, et al.
Published: (2025-12-01) -
Nutrient-gene therapy as a strategy to enhance CAR T cell function and overcome barriers in the tumor microenvironment
by: Brandon Park, et al.
Published: (2025-06-01)